Patents Assigned to ReCyte Therapeutics, Inc.
  • Exosomes from clonal progenitor cells
    Patent number: 11274281
    Abstract: The invention provides methods, compositions, uses and kits relating to exosomes isolated from progenitor cells.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: March 15, 2022
    Assignee: ReCyte Therapeutics, Inc.
    Inventors: Dana Larocca, Mohammad Hassanipour, Paola A. Bignone
  • Perivascular stromal cells from primate pluripotent stem cells
    Patent number: 11078462
    Abstract: The invention provides methods, compositions and kits for making and using pericyte-like cells or perivascular stromal cells derived from pPS cells.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: August 3, 2021
    Assignee: ReCyte Therapeutics, Inc.
    Inventors: Jiwei Yang, Dana Larocca, Midori Greenwood-Goodwin
  • Exosomes from clonal progenitor cells
    Patent number: 10240127
    Abstract: The invention provides methods, compositions, uses and kits relating to exosomes isolated from progenitor cells.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: March 26, 2019
    Assignee: ReCyte Therapeutics, Inc.
    Inventors: Dana Larocca, Mohammad Hassanipour, Paola A. Bignone